nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PGD—Dacarbazine—pancreatic cancer	0.712	1	CbGbCtD
Ketotifen—Haematochezia—Erlotinib—pancreatic cancer	0.00454	0.042	CcSEcCtD
Ketotifen—Haematochezia—Sunitinib—pancreatic cancer	0.00393	0.0363	CcSEcCtD
Ketotifen—Eyelid oedema—Sunitinib—pancreatic cancer	0.00314	0.029	CcSEcCtD
Ketotifen—Dry eye—Erlotinib—pancreatic cancer	0.00169	0.0156	CcSEcCtD
Ketotifen—Tingling sensation—Fluorouracil—pancreatic cancer	0.00155	0.0144	CcSEcCtD
Ketotifen—Stinging—Fluorouracil—pancreatic cancer	0.00154	0.0143	CcSEcCtD
Ketotifen—Haematochezia—Epirubicin—pancreatic cancer	0.00151	0.014	CcSEcCtD
Ketotifen—Haematochezia—Doxorubicin—pancreatic cancer	0.0014	0.0129	CcSEcCtD
Ketotifen—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.00134	0.0124	CcSEcCtD
Ketotifen—Weight increased—Tamoxifen—pancreatic cancer	0.00106	0.00976	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00102	0.00948	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00101	0.00938	CcSEcCtD
Ketotifen—Epistaxis—Erlotinib—pancreatic cancer	0.000965	0.00892	CcSEcCtD
Ketotifen—Hepatitis—Tamoxifen—pancreatic cancer	0.000928	0.00858	CcSEcCtD
Ketotifen—Hepatitis—Erlotinib—pancreatic cancer	0.000918	0.00849	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.000878	0.00812	CcSEcCtD
Ketotifen—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000877	0.00811	CcSEcCtD
Ketotifen—Erythema multiforme—Erlotinib—pancreatic cancer	0.000868	0.00803	CcSEcCtD
Ketotifen—Irritability—Fluorouracil—pancreatic cancer	0.000865	0.008	CcSEcCtD
Ketotifen—Epistaxis—Sunitinib—pancreatic cancer	0.000835	0.00772	CcSEcCtD
Ketotifen—Hepatitis—Sunitinib—pancreatic cancer	0.000795	0.00735	CcSEcCtD
Ketotifen—Erythema multiforme—Sunitinib—pancreatic cancer	0.000751	0.00695	CcSEcCtD
Ketotifen—Stinging—Epirubicin—pancreatic cancer	0.00075	0.00694	CcSEcCtD
Ketotifen—Syncope—Erlotinib—pancreatic cancer	0.000717	0.00663	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000704	0.00651	CcSEcCtD
Ketotifen—Loss of consciousness—Erlotinib—pancreatic cancer	0.000702	0.0065	CcSEcCtD
Ketotifen—Hypertension—Tamoxifen—pancreatic cancer	0.000697	0.00645	CcSEcCtD
Ketotifen—Stinging—Doxorubicin—pancreatic cancer	0.000694	0.00642	CcSEcCtD
Ketotifen—Dry mouth—Tamoxifen—pancreatic cancer	0.000673	0.00622	CcSEcCtD
Ketotifen—Epistaxis—Fluorouracil—pancreatic cancer	0.000659	0.00609	CcSEcCtD
Ketotifen—Infection—Tamoxifen—pancreatic cancer	0.000655	0.00606	CcSEcCtD
Ketotifen—Infection—Erlotinib—pancreatic cancer	0.000648	0.00599	CcSEcCtD
Ketotifen—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000645	0.00597	CcSEcCtD
Ketotifen—Shock—Erlotinib—pancreatic cancer	0.000642	0.00593	CcSEcCtD
Ketotifen—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000639	0.00591	CcSEcCtD
Ketotifen—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000603	0.00558	CcSEcCtD
Ketotifen—Hypertension—Sunitinib—pancreatic cancer	0.000597	0.00552	CcSEcCtD
Ketotifen—Insomnia—Tamoxifen—pancreatic cancer	0.000596	0.00551	CcSEcCtD
Ketotifen—Cystitis noninfective—Epirubicin—pancreatic cancer	0.000594	0.00549	CcSEcCtD
Ketotifen—Paraesthesia—Tamoxifen—pancreatic cancer	0.000592	0.00547	CcSEcCtD
Ketotifen—Insomnia—Erlotinib—pancreatic cancer	0.00059	0.00546	CcSEcCtD
Ketotifen—Cystitis—Epirubicin—pancreatic cancer	0.000587	0.00543	CcSEcCtD
Ketotifen—Dry mouth—Sunitinib—pancreatic cancer	0.000576	0.00533	CcSEcCtD
Ketotifen—Pain—Tamoxifen—pancreatic cancer	0.000564	0.00521	CcSEcCtD
Ketotifen—Dry eye—Epirubicin—pancreatic cancer	0.000561	0.00519	CcSEcCtD
Ketotifen—Infection—Sunitinib—pancreatic cancer	0.000561	0.00519	CcSEcCtD
Ketotifen—Pain—Erlotinib—pancreatic cancer	0.000558	0.00516	CcSEcCtD
Ketotifen—Shock—Sunitinib—pancreatic cancer	0.000556	0.00514	CcSEcCtD
Ketotifen—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000553	0.00511	CcSEcCtD
Ketotifen—Bladder pain—Epirubicin—pancreatic cancer	0.00055	0.00508	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—pancreatic cancer	0.000549	0.00508	CcSEcCtD
Ketotifen—Cystitis—Doxorubicin—pancreatic cancer	0.000543	0.00502	CcSEcCtD
Ketotifen—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000539	0.00498	CcSEcCtD
Ketotifen—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000533	0.00493	CcSEcCtD
Ketotifen—Urticaria—Tamoxifen—pancreatic cancer	0.000524	0.00484	CcSEcCtD
Ketotifen—Abdominal pain—Tamoxifen—pancreatic cancer	0.000521	0.00482	CcSEcCtD
Ketotifen—Dry eye—Doxorubicin—pancreatic cancer	0.000519	0.0048	CcSEcCtD
Ketotifen—Body temperature increased—Erlotinib—pancreatic cancer	0.000516	0.00477	CcSEcCtD
Ketotifen—Abdominal pain—Erlotinib—pancreatic cancer	0.000516	0.00477	CcSEcCtD
Ketotifen—Weight increased—Docetaxel—pancreatic cancer	0.000515	0.00476	CcSEcCtD
Ketotifen—Syncope—Irinotecan—pancreatic cancer	0.000511	0.00473	CcSEcCtD
Ketotifen—Insomnia—Sunitinib—pancreatic cancer	0.000511	0.00472	CcSEcCtD
Ketotifen—Bladder pain—Doxorubicin—pancreatic cancer	0.000508	0.0047	CcSEcCtD
Ketotifen—Paraesthesia—Sunitinib—pancreatic cancer	0.000507	0.00469	CcSEcCtD
Ketotifen—Loss of consciousness—Irinotecan—pancreatic cancer	0.000501	0.00463	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.0005	0.00462	CcSEcCtD
Ketotifen—Hypertension—Irinotecan—pancreatic cancer	0.000492	0.00455	CcSEcCtD
Ketotifen—Pain—Sunitinib—pancreatic cancer	0.000483	0.00446	CcSEcCtD
Ketotifen—Hypertension—Gemcitabine—pancreatic cancer	0.000479	0.00443	CcSEcCtD
Ketotifen—Epistaxis—Docetaxel—pancreatic cancer	0.000475	0.0044	CcSEcCtD
Ketotifen—Increased appetite—Epirubicin—pancreatic cancer	0.00047	0.00434	CcSEcCtD
Ketotifen—Pruritus—Tamoxifen—pancreatic cancer	0.000466	0.00431	CcSEcCtD
Ketotifen—Infection—Irinotecan—pancreatic cancer	0.000462	0.00427	CcSEcCtD
Ketotifen—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000462	0.00427	CcSEcCtD
Ketotifen—Pruritus—Erlotinib—pancreatic cancer	0.000461	0.00427	CcSEcCtD
Ketotifen—Shock—Irinotecan—pancreatic cancer	0.000458	0.00423	CcSEcCtD
Ketotifen—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000455	0.00421	CcSEcCtD
Ketotifen—Hepatitis—Docetaxel—pancreatic cancer	0.000453	0.00418	CcSEcCtD
Ketotifen—Diarrhoea—Tamoxifen—pancreatic cancer	0.000451	0.00417	CcSEcCtD
Ketotifen—Infection—Gemcitabine—pancreatic cancer	0.00045	0.00416	CcSEcCtD
Ketotifen—Abdominal pain—Sunitinib—pancreatic cancer	0.000446	0.00413	CcSEcCtD
Ketotifen—Body temperature increased—Sunitinib—pancreatic cancer	0.000446	0.00413	CcSEcCtD
Ketotifen—Diarrhoea—Erlotinib—pancreatic cancer	0.000446	0.00413	CcSEcCtD
Ketotifen—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000444	0.0041	CcSEcCtD
Ketotifen—Infection—Fluorouracil—pancreatic cancer	0.000443	0.00409	CcSEcCtD
Ketotifen—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000436	0.00403	CcSEcCtD
Ketotifen—Dizziness—Tamoxifen—pancreatic cancer	0.000436	0.00403	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—pancreatic cancer	0.000435	0.00402	CcSEcCtD
Ketotifen—Dizziness—Erlotinib—pancreatic cancer	0.000431	0.00399	CcSEcCtD
Ketotifen—Erythema multiforme—Docetaxel—pancreatic cancer	0.000428	0.00396	CcSEcCtD
Ketotifen—Insomnia—Irinotecan—pancreatic cancer	0.000421	0.00389	CcSEcCtD
Ketotifen—Vomiting—Tamoxifen—pancreatic cancer	0.000419	0.00388	CcSEcCtD
Ketotifen—Paraesthesia—Irinotecan—pancreatic cancer	0.000418	0.00386	CcSEcCtD
Ketotifen—Rash—Tamoxifen—pancreatic cancer	0.000416	0.00384	CcSEcCtD
Ketotifen—Dermatitis—Tamoxifen—pancreatic cancer	0.000415	0.00384	CcSEcCtD
Ketotifen—Vomiting—Erlotinib—pancreatic cancer	0.000415	0.00383	CcSEcCtD
Ketotifen—Somnolence—Irinotecan—pancreatic cancer	0.000413	0.00382	CcSEcCtD
Ketotifen—Headache—Tamoxifen—pancreatic cancer	0.000413	0.00382	CcSEcCtD
Ketotifen—Rash—Erlotinib—pancreatic cancer	0.000411	0.0038	CcSEcCtD
Ketotifen—Dermatitis—Erlotinib—pancreatic cancer	0.000411	0.0038	CcSEcCtD
Ketotifen—Insomnia—Gemcitabine—pancreatic cancer	0.00041	0.00379	CcSEcCtD
Ketotifen—Headache—Erlotinib—pancreatic cancer	0.000409	0.00378	CcSEcCtD
Ketotifen—Paraesthesia—Gemcitabine—pancreatic cancer	0.000407	0.00376	CcSEcCtD
Ketotifen—Insomnia—Fluorouracil—pancreatic cancer	0.000403	0.00373	CcSEcCtD
Ketotifen—Somnolence—Gemcitabine—pancreatic cancer	0.000403	0.00372	CcSEcCtD
Ketotifen—Paraesthesia—Fluorouracil—pancreatic cancer	0.0004	0.0037	CcSEcCtD
Ketotifen—Pruritus—Sunitinib—pancreatic cancer	0.000399	0.00369	CcSEcCtD
Ketotifen—Pain—Irinotecan—pancreatic cancer	0.000398	0.00368	CcSEcCtD
Ketotifen—Somnolence—Fluorouracil—pancreatic cancer	0.000396	0.00366	CcSEcCtD
Ketotifen—Nausea—Tamoxifen—pancreatic cancer	0.000392	0.00362	CcSEcCtD
Ketotifen—Pain—Gemcitabine—pancreatic cancer	0.000387	0.00358	CcSEcCtD
Ketotifen—Nausea—Erlotinib—pancreatic cancer	0.000387	0.00358	CcSEcCtD
Ketotifen—Diarrhoea—Sunitinib—pancreatic cancer	0.000386	0.00357	CcSEcCtD
Ketotifen—Pain—Fluorouracil—pancreatic cancer	0.000381	0.00352	CcSEcCtD
Ketotifen—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00038	0.00352	CcSEcCtD
Ketotifen—Dizziness—Sunitinib—pancreatic cancer	0.000373	0.00345	CcSEcCtD
Ketotifen—Abdominal pain—Irinotecan—pancreatic cancer	0.000368	0.0034	CcSEcCtD
Ketotifen—Body temperature increased—Irinotecan—pancreatic cancer	0.000368	0.0034	CcSEcCtD
Ketotifen—Vomiting—Sunitinib—pancreatic cancer	0.000359	0.00332	CcSEcCtD
Ketotifen—Body temperature increased—Gemcitabine—pancreatic cancer	0.000358	0.00331	CcSEcCtD
Ketotifen—Rash—Sunitinib—pancreatic cancer	0.000356	0.00329	CcSEcCtD
Ketotifen—Dermatitis—Sunitinib—pancreatic cancer	0.000356	0.00329	CcSEcCtD
Ketotifen—Urticaria—Fluorouracil—pancreatic cancer	0.000354	0.00327	CcSEcCtD
Ketotifen—Headache—Sunitinib—pancreatic cancer	0.000354	0.00327	CcSEcCtD
Ketotifen—Syncope—Docetaxel—pancreatic cancer	0.000353	0.00327	CcSEcCtD
Ketotifen—Body temperature increased—Fluorouracil—pancreatic cancer	0.000352	0.00326	CcSEcCtD
Ketotifen—Weight increased—Epirubicin—pancreatic cancer	0.000347	0.00321	CcSEcCtD
Ketotifen—Loss of consciousness—Docetaxel—pancreatic cancer	0.000346	0.0032	CcSEcCtD
Ketotifen—Hypertension—Docetaxel—pancreatic cancer	0.00034	0.00315	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—pancreatic cancer	0.00034	0.00314	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000337	0.00312	CcSEcCtD
Ketotifen—Nausea—Sunitinib—pancreatic cancer	0.000335	0.0031	CcSEcCtD
Ketotifen—Dry mouth—Docetaxel—pancreatic cancer	0.000328	0.00303	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—pancreatic cancer	0.000321	0.00297	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—pancreatic cancer	0.000321	0.00297	CcSEcCtD
Ketotifen—Pruritus—Gemcitabine—pancreatic cancer	0.000321	0.00296	CcSEcCtD
Ketotifen—Infection—Docetaxel—pancreatic cancer	0.000319	0.00295	CcSEcCtD
Ketotifen—Diarrhoea—Irinotecan—pancreatic cancer	0.000318	0.00294	CcSEcCtD
Ketotifen—Shock—Docetaxel—pancreatic cancer	0.000316	0.00292	CcSEcCtD
Ketotifen—Pruritus—Fluorouracil—pancreatic cancer	0.000315	0.00291	CcSEcCtD
Ketotifen—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000315	0.00291	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—pancreatic cancer	0.000315	0.00291	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000312	0.00288	CcSEcCtD
Ketotifen—Diarrhoea—Gemcitabine—pancreatic cancer	0.00031	0.00287	CcSEcCtD
Ketotifen—Dizziness—Irinotecan—pancreatic cancer	0.000308	0.00284	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—pancreatic cancer	0.000305	0.00282	CcSEcCtD
Ketotifen—Diarrhoea—Fluorouracil—pancreatic cancer	0.000305	0.00282	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—pancreatic cancer	0.000297	0.00274	CcSEcCtD
Ketotifen—Vomiting—Irinotecan—pancreatic cancer	0.000296	0.00273	CcSEcCtD
Ketotifen—Dizziness—Fluorouracil—pancreatic cancer	0.000295	0.00272	CcSEcCtD
Ketotifen—Rash—Irinotecan—pancreatic cancer	0.000293	0.00271	CcSEcCtD
Ketotifen—Dermatitis—Irinotecan—pancreatic cancer	0.000293	0.00271	CcSEcCtD
Ketotifen—Headache—Irinotecan—pancreatic cancer	0.000291	0.00269	CcSEcCtD
Ketotifen—Insomnia—Docetaxel—pancreatic cancer	0.000291	0.00269	CcSEcCtD
Ketotifen—Paraesthesia—Docetaxel—pancreatic cancer	0.000289	0.00267	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—pancreatic cancer	0.000289	0.00267	CcSEcCtD
Ketotifen—Vomiting—Gemcitabine—pancreatic cancer	0.000288	0.00266	CcSEcCtD
Ketotifen—Somnolence—Docetaxel—pancreatic cancer	0.000286	0.00264	CcSEcCtD
Ketotifen—Rash—Gemcitabine—pancreatic cancer	0.000286	0.00264	CcSEcCtD
Ketotifen—Dermatitis—Gemcitabine—pancreatic cancer	0.000285	0.00264	CcSEcCtD
Ketotifen—Headache—Gemcitabine—pancreatic cancer	0.000284	0.00262	CcSEcCtD
Ketotifen—Vomiting—Fluorouracil—pancreatic cancer	0.000283	0.00262	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—pancreatic cancer	0.000282	0.00261	CcSEcCtD
Ketotifen—Rash—Fluorouracil—pancreatic cancer	0.000281	0.0026	CcSEcCtD
Ketotifen—Dermatitis—Fluorouracil—pancreatic cancer	0.000281	0.00259	CcSEcCtD
Ketotifen—Headache—Fluorouracil—pancreatic cancer	0.000279	0.00258	CcSEcCtD
Ketotifen—Nausea—Irinotecan—pancreatic cancer	0.000276	0.00255	CcSEcCtD
Ketotifen—Pain—Docetaxel—pancreatic cancer	0.000275	0.00254	CcSEcCtD
Ketotifen—Nausea—Gemcitabine—pancreatic cancer	0.000269	0.00249	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000267	0.00247	CcSEcCtD
Ketotifen—Nausea—Fluorouracil—pancreatic cancer	0.000265	0.00245	CcSEcCtD
Ketotifen—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000263	0.00243	CcSEcCtD
Ketotifen—Tension—Epirubicin—pancreatic cancer	0.000261	0.00241	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—pancreatic cancer	0.000258	0.00239	CcSEcCtD
Ketotifen—Body temperature increased—Docetaxel—pancreatic cancer	0.000254	0.00235	CcSEcCtD
Ketotifen—Abdominal pain—Docetaxel—pancreatic cancer	0.000254	0.00235	CcSEcCtD
Ketotifen—Tension—Doxorubicin—pancreatic cancer	0.000241	0.00223	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—pancreatic cancer	0.000239	0.00221	CcSEcCtD
Ketotifen—Syncope—Epirubicin—pancreatic cancer	0.000238	0.0022	CcSEcCtD
Ketotifen—Loss of consciousness—Epirubicin—pancreatic cancer	0.000234	0.00216	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—pancreatic cancer	0.000229	0.00212	CcSEcCtD
Ketotifen—Pruritus—Docetaxel—pancreatic cancer	0.000227	0.0021	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—pancreatic cancer	0.000221	0.00205	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—pancreatic cancer	0.00022	0.00204	CcSEcCtD
Ketotifen—Diarrhoea—Docetaxel—pancreatic cancer	0.00022	0.00203	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000216	0.002	CcSEcCtD
Ketotifen—Infection—Epirubicin—pancreatic cancer	0.000215	0.00199	CcSEcCtD
Ketotifen—Shock—Epirubicin—pancreatic cancer	0.000213	0.00197	CcSEcCtD
Ketotifen—Dizziness—Docetaxel—pancreatic cancer	0.000213	0.00197	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000212	0.00196	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—pancreatic cancer	0.000212	0.00196	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—pancreatic cancer	0.000205	0.00189	CcSEcCtD
Ketotifen—Vomiting—Docetaxel—pancreatic cancer	0.000204	0.00189	CcSEcCtD
Ketotifen—Rash—Docetaxel—pancreatic cancer	0.000203	0.00187	CcSEcCtD
Ketotifen—Dermatitis—Docetaxel—pancreatic cancer	0.000203	0.00187	CcSEcCtD
Ketotifen—Headache—Docetaxel—pancreatic cancer	0.000201	0.00186	CcSEcCtD
Ketotifen—Infection—Doxorubicin—pancreatic cancer	0.000199	0.00184	CcSEcCtD
Ketotifen—Shock—Doxorubicin—pancreatic cancer	0.000197	0.00183	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000196	0.00182	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—pancreatic cancer	0.000196	0.00181	CcSEcCtD
Ketotifen—Paraesthesia—Epirubicin—pancreatic cancer	0.000195	0.0018	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—pancreatic cancer	0.000193	0.00178	CcSEcCtD
Ketotifen—Nausea—Docetaxel—pancreatic cancer	0.000191	0.00177	CcSEcCtD
Ketotifen—Pain—Epirubicin—pancreatic cancer	0.000185	0.00171	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—pancreatic cancer	0.000181	0.00168	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—pancreatic cancer	0.00018	0.00167	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—pancreatic cancer	0.000178	0.00165	CcSEcCtD
Ketotifen—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000177	0.00164	CcSEcCtD
Ketotifen—Urticaria—Epirubicin—pancreatic cancer	0.000172	0.00159	CcSEcCtD
Ketotifen—Pain—Doxorubicin—pancreatic cancer	0.000172	0.00159	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—pancreatic cancer	0.000171	0.00159	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—pancreatic cancer	0.000171	0.00159	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000164	0.00152	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—pancreatic cancer	0.000159	0.00147	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—pancreatic cancer	0.000159	0.00147	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—pancreatic cancer	0.000159	0.00147	CcSEcCtD
Ketotifen—Pruritus—Epirubicin—pancreatic cancer	0.000153	0.00142	CcSEcCtD
Ketotifen—Diarrhoea—Epirubicin—pancreatic cancer	0.000148	0.00137	CcSEcCtD
Ketotifen—Dizziness—Epirubicin—pancreatic cancer	0.000143	0.00133	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—pancreatic cancer	0.000142	0.00131	CcSEcCtD
Ketotifen—Vomiting—Epirubicin—pancreatic cancer	0.000138	0.00127	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—pancreatic cancer	0.000137	0.00127	CcSEcCtD
Ketotifen—Rash—Epirubicin—pancreatic cancer	0.000137	0.00126	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—pancreatic cancer	0.000137	0.00126	CcSEcCtD
Ketotifen—Headache—Epirubicin—pancreatic cancer	0.000136	0.00126	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—pancreatic cancer	0.000133	0.00123	CcSEcCtD
Ketotifen—Nausea—Epirubicin—pancreatic cancer	0.000129	0.00119	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—pancreatic cancer	0.000128	0.00118	CcSEcCtD
Ketotifen—Rash—Doxorubicin—pancreatic cancer	0.000127	0.00117	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—pancreatic cancer	0.000126	0.00117	CcSEcCtD
Ketotifen—Headache—Doxorubicin—pancreatic cancer	0.000126	0.00116	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—pancreatic cancer	0.000119	0.0011	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—STAT3—pancreatic cancer	3.18e-05	0.000177	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	3.18e-05	0.000177	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—NRAS—pancreatic cancer	3.18e-05	0.000177	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRP1—pancreatic cancer	3.16e-05	0.000176	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	3.16e-05	0.000176	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—APOE—pancreatic cancer	3.14e-05	0.000175	CbGpPWpGaD
Ketotifen—PGD—Disease—KRAS—pancreatic cancer	3.12e-05	0.000174	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CXCL8—pancreatic cancer	3.11e-05	0.000173	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KDR—pancreatic cancer	3.08e-05	0.000171	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—SRC—pancreatic cancer	3.07e-05	0.000171	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—GCG—pancreatic cancer	3.07e-05	0.000171	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—KRAS—pancreatic cancer	3.07e-05	0.000171	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—KRAS—pancreatic cancer	3.07e-05	0.000171	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HIF1A—pancreatic cancer	3.06e-05	0.00017	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TSC2—pancreatic cancer	3.06e-05	0.00017	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HEY2—pancreatic cancer	3.04e-05	0.000169	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—APOE—pancreatic cancer	2.99e-05	0.000166	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—VEGFA—pancreatic cancer	2.99e-05	0.000166	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—EGFR—pancreatic cancer	2.97e-05	0.000165	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GAST—pancreatic cancer	2.97e-05	0.000165	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TERT—pancreatic cancer	2.96e-05	0.000165	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—STAT3—pancreatic cancer	2.96e-05	0.000165	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—MYC—pancreatic cancer	2.96e-05	0.000165	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—NRAS—pancreatic cancer	2.95e-05	0.000164	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TGFB1—pancreatic cancer	2.95e-05	0.000164	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	2.94e-05	0.000164	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KDR—pancreatic cancer	2.93e-05	0.000163	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NFKBIA—pancreatic cancer	2.93e-05	0.000163	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	2.93e-05	0.000163	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NOTCH1—pancreatic cancer	2.9e-05	0.000161	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—EGFR—pancreatic cancer	2.89e-05	0.000161	CbGpPWpGaD
Ketotifen—PGD—Disease—PIK3CA—pancreatic cancer	2.87e-05	0.00016	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CD—pancreatic cancer	2.86e-05	0.000159	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.84e-05	0.000158	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CG—pancreatic cancer	2.84e-05	0.000158	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—NRAS—pancreatic cancer	2.84e-05	0.000158	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HIF1A—pancreatic cancer	2.83e-05	0.000158	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TSC2—pancreatic cancer	2.83e-05	0.000157	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PIK3CA—pancreatic cancer	2.82e-05	0.000157	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PIK3CA—pancreatic cancer	2.82e-05	0.000157	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SCT—pancreatic cancer	2.81e-05	0.000157	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HEY1—pancreatic cancer	2.81e-05	0.000157	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—KRAS—pancreatic cancer	2.8e-05	0.000156	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGF—pancreatic cancer	2.8e-05	0.000156	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NFKBIA—pancreatic cancer	2.79e-05	0.000155	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—APOE—pancreatic cancer	2.77e-05	0.000154	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NOTCH1—pancreatic cancer	2.76e-05	0.000154	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MYC—pancreatic cancer	2.75e-05	0.000153	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TGFB1—pancreatic cancer	2.74e-05	0.000153	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—KRAS—pancreatic cancer	2.73e-05	0.000152	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—pancreatic cancer	2.73e-05	0.000152	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—pancreatic cancer	2.73e-05	0.000152	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.72e-05	0.000151	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KDR—pancreatic cancer	2.71e-05	0.000151	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CG—pancreatic cancer	2.7e-05	0.00015	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—NRAS—pancreatic cancer	2.7e-05	0.00015	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—EGFR—pancreatic cancer	2.69e-05	0.00015	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCK—pancreatic cancer	2.68e-05	0.000149	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGF—pancreatic cancer	2.67e-05	0.000148	CbGpPWpGaD
Ketotifen—PGD—Disease—HRAS—pancreatic cancer	2.65e-05	0.000148	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CNR2—pancreatic cancer	2.62e-05	0.000146	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	2.62e-05	0.000146	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	2.61e-05	0.000145	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—HRAS—pancreatic cancer	2.61e-05	0.000145	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—HRAS—pancreatic cancer	2.61e-05	0.000145	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—EGFR—pancreatic cancer	2.58e-05	0.000144	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NFKBIA—pancreatic cancer	2.58e-05	0.000143	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PIK3CA—pancreatic cancer	2.58e-05	0.000143	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	2.57e-05	0.000143	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NOTCH1—pancreatic cancer	2.55e-05	0.000142	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—KRAS—pancreatic cancer	2.54e-05	0.000141	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PIK3CA—pancreatic cancer	2.51e-05	0.00014	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CG—pancreatic cancer	2.5e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—NRAS—pancreatic cancer	2.5e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CB—pancreatic cancer	2.5e-05	0.000139	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JAG2—pancreatic cancer	2.49e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CD—pancreatic cancer	2.49e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.47e-05	0.000137	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGF—pancreatic cancer	2.47e-05	0.000137	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—EGFR—pancreatic cancer	2.46e-05	0.000137	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MEN1—pancreatic cancer	2.46e-05	0.000137	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—pancreatic cancer	2.44e-05	0.000136	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—pancreatic cancer	2.43e-05	0.000135	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PIK3CA—pancreatic cancer	2.4e-05	0.000134	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCL8—pancreatic cancer	2.4e-05	0.000133	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—HRAS—pancreatic cancer	2.38e-05	0.000133	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CD—pancreatic cancer	2.37e-05	0.000132	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.35e-05	0.000131	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SHH—pancreatic cancer	2.35e-05	0.000131	CbGpPWpGaD
Ketotifen—PGD—Disease—AKT1—pancreatic cancer	2.34e-05	0.00013	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PIK3CA—pancreatic cancer	2.33e-05	0.00013	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	2.33e-05	0.00013	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—HRAS—pancreatic cancer	2.32e-05	0.000129	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—pancreatic cancer	2.32e-05	0.000129	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—AKT1—pancreatic cancer	2.32e-05	0.000129	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IAPP—pancreatic cancer	2.32e-05	0.000129	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—AKT1—pancreatic cancer	2.3e-05	0.000128	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—AKT1—pancreatic cancer	2.3e-05	0.000128	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CASP3—pancreatic cancer	2.3e-05	0.000128	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—EGFR—pancreatic cancer	2.28e-05	0.000127	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—pancreatic cancer	2.26e-05	0.000126	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PIK3CA—pancreatic cancer	2.24e-05	0.000125	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCND1—pancreatic cancer	2.23e-05	0.000124	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	2.22e-05	0.000124	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	2.22e-05	0.000124	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—pancreatic cancer	2.21e-05	0.000123	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CD—pancreatic cancer	2.2e-05	0.000122	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.17e-05	0.000121	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CB—pancreatic cancer	2.17e-05	0.000121	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MMP9—pancreatic cancer	2.17e-05	0.000121	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—HRAS—pancreatic cancer	2.16e-05	0.00012	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—pancreatic cancer	2.16e-05	0.00012	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—pancreatic cancer	2.15e-05	0.00012	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.13e-05	0.000119	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—AKT1—pancreatic cancer	2.1e-05	0.000117	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL8—pancreatic cancer	2.09e-05	0.000116	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—HRAS—pancreatic cancer	2.07e-05	0.000115	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CB—pancreatic cancer	2.07e-05	0.000115	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—AKT1—pancreatic cancer	2.05e-05	0.000114	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SST—pancreatic cancer	2.03e-05	0.000113	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—AKT1—pancreatic cancer	2.02e-05	0.000112	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.01e-05	0.000112	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SRC—pancreatic cancer	2e-05	0.000111	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CASP3—pancreatic cancer	2e-05	0.000111	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JAG1—pancreatic cancer	1.99e-05	0.000111	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL8—pancreatic cancer	1.99e-05	0.000111	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	1.98e-05	0.00011	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.97e-05	0.00011	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—HRAS—pancreatic cancer	1.97e-05	0.00011	CbGpPWpGaD
Ketotifen—PGD—Metabolism—AKT1—pancreatic cancer	1.96e-05	0.000109	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—pancreatic cancer	1.95e-05	0.000108	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCND1—pancreatic cancer	1.95e-05	0.000108	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—STAT3—pancreatic cancer	1.93e-05	0.000107	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—pancreatic cancer	1.93e-05	0.000107	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—NRAS—pancreatic cancer	1.92e-05	0.000107	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—AKT1—pancreatic cancer	1.92e-05	0.000107	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CB—pancreatic cancer	1.91e-05	0.000106	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—AKT1—pancreatic cancer	1.91e-05	0.000106	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CASP3—pancreatic cancer	1.9e-05	0.000106	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MMP9—pancreatic cancer	1.89e-05	0.000105	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—pancreatic cancer	1.88e-05	0.000104	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CNR1—pancreatic cancer	1.88e-05	0.000104	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCND1—pancreatic cancer	1.85e-05	0.000103	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL8—pancreatic cancer	1.84e-05	0.000102	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—pancreatic cancer	1.83e-05	0.000102	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—AKT1—pancreatic cancer	1.83e-05	0.000102	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—HRAS—pancreatic cancer	1.83e-05	0.000102	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.82e-05	0.000101	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GCG—pancreatic cancer	1.81e-05	0.000101	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MMP9—pancreatic cancer	1.8e-05	0.0001	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MYC—pancreatic cancer	1.79e-05	9.97e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TGFB1—pancreatic cancer	1.79e-05	9.95e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—pancreatic cancer	1.79e-05	9.94e-05	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—AKT1—pancreatic cancer	1.78e-05	9.88e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.76e-05	9.81e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CASP3—pancreatic cancer	1.76e-05	9.79e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EGFR—pancreatic cancer	1.75e-05	9.75e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—AKT1—pancreatic cancer	1.74e-05	9.7e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SRC—pancreatic cancer	1.74e-05	9.69e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	1.73e-05	9.62e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCND1—pancreatic cancer	1.71e-05	9.53e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STK11—pancreatic cancer	1.7e-05	9.48e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—pancreatic cancer	1.7e-05	9.44e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—pancreatic cancer	1.7e-05	9.44e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—STAT3—pancreatic cancer	1.68e-05	9.34e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NRAS—pancreatic cancer	1.68e-05	9.32e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MMP9—pancreatic cancer	1.66e-05	9.25e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SRC—pancreatic cancer	1.66e-05	9.22e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—pancreatic cancer	1.66e-05	9.21e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	1.65e-05	9.2e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	1.61e-05	8.98e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	1.61e-05	8.98e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.6e-05	8.91e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	1.6e-05	8.89e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	1.59e-05	8.87e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MYC—pancreatic cancer	1.56e-05	8.68e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TGFB1—pancreatic cancer	1.56e-05	8.66e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.54e-05	8.55e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SRC—pancreatic cancer	1.53e-05	8.53e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGFR—pancreatic cancer	1.53e-05	8.49e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—pancreatic cancer	1.52e-05	8.47e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	1.49e-05	8.31e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	1.49e-05	8.31e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MYC—pancreatic cancer	1.49e-05	8.26e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	1.48e-05	8.24e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	8.23e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.48e-05	8.22e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	1.48e-05	8.21e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—pancreatic cancer	1.47e-05	8.19e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HES1—pancreatic cancer	1.46e-05	8.11e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	1.45e-05	8.08e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—pancreatic cancer	1.44e-05	8.02e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HRAS—pancreatic cancer	1.41e-05	7.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.4e-05	7.77e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MYC—pancreatic cancer	1.37e-05	7.65e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	1.37e-05	7.64e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	1.37e-05	7.63e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	1.34e-05	7.48e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	1.34e-05	7.46e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—pancreatic cancer	1.32e-05	7.37e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—pancreatic cancer	1.28e-05	7.13e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TERT—pancreatic cancer	1.28e-05	7.11e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	7.06e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	1.26e-05	7.01e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—AKT1—pancreatic cancer	1.24e-05	6.92e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HRAS—pancreatic cancer	1.23e-05	6.82e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.22e-05	6.8e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—pancreatic cancer	1.22e-05	6.79e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.22e-05	6.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.19e-05	6.63e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.17e-05	6.5e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	1.17e-05	6.49e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	1.17e-05	6.49e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	6.28e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	1.11e-05	6.18e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	1.1e-05	6.12e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—AKT1—pancreatic cancer	1.08e-05	6.02e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	6.01e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	1.08e-05	5.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	1.08e-05	5.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.06e-05	5.92e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	1.03e-05	5.73e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	9.8e-06	5.45e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	9.53e-06	5.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	9.46e-06	5.26e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.37e-06	5.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	9.26e-06	5.15e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	8.51e-06	4.73e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	8.25e-06	4.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	7.92e-06	4.41e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	7.87e-06	4.38e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	7.65e-06	4.26e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP3—pancreatic cancer	7.58e-06	4.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCND1—pancreatic cancer	7.38e-06	4.11e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	7.31e-06	4.07e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP9—pancreatic cancer	7.17e-06	3.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—pancreatic cancer	7.12e-06	3.96e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	6.95e-06	3.87e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SRC—pancreatic cancer	6.61e-06	3.68e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	6.44e-06	3.58e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STAT3—pancreatic cancer	6.37e-06	3.55e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRAS—pancreatic cancer	6.36e-06	3.54e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MYC—pancreatic cancer	5.92e-06	3.29e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	5.91e-06	3.29e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGFR—pancreatic cancer	5.79e-06	3.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—pancreatic cancer	5.47e-06	3.04e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	5.03e-06	2.8e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.86e-06	2.71e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HRAS—pancreatic cancer	4.65e-06	2.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT1—pancreatic cancer	4.11e-06	2.28e-05	CbGpPWpGaD
